Elevated Capital Advisors, LLC Gsk PLC Transaction History

Elevated Capital Advisors, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 17, 2023	SELL	$30.0 - $37.92 $1.04 Million - $1.31 Million	-34,505 Closed	0 $0
Q3 2022 Oct 06, 2022	BUY	$16.13 - $44.61 $180,768 - $499,944	11,207 Added 48.1%	34,505 $1.02 Million
Q1 2022 Apr 20, 2022	BUY	$40.23 - $47.74 $131,994 - $156,634	3,281 Added 16.39%	23,298 $1.02 Million
Q3 2021 Oct 07, 2021	BUY	$38.79 - $43.16 $123,856 - $137,809	3,193 Added 18.98%	20,017 $765,000
Q1 2021 Apr 21, 2021	BUY	$34.27 - $40.01 $29,883 - $34,888	872 Added 5.47%	16,824 $634,000
Q4 2020 Feb 25, 2021	SELL	$34.07 - $39.94 $33,218 - $38,941	-975 Reduced 5.76%	15,952 $587,000
Q3 2020 Nov 27, 2020	SELL	$38.11 - $42.99 $24,047 - $27,126	-631 Reduced 3.59%	16,927 $657,000
Q2 2020 Sep 11, 2020	BUY	$37.87 - $43.58 $327,272 - $376,618	8,642 Added 96.93%	17,558 $701,000
Q4 2019 Feb 06, 2020	SELL	$42.0 - $48.25 $494,508 - $568,095	-11,774 Reduced 56.91%	8,916 $419,000
Q1 2019 Apr 16, 2020	BUY	$38.57 - $42.69 $798,013 - $883,256	20,690 New	20,690 $824,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Elevated Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Elevated Capital Advisors, LLC with notifications on news.